Financial Performance - The company expects a net loss of approximately -1.90 million yuan for the reporting period, compared to a profit of 18.15 million yuan in the same period last year[4]. - The financial data presented is preliminary and has not been audited, with final figures to be disclosed in the annual report[2][7]. - Investors are advised to be cautious regarding investment risks associated with the company's financial performance[7]. Sales and Revenue - The primary reason for the net loss is the decline in sales revenue of high-margin microbial preparations, while lower-margin feed products have increased their revenue share[6]. - The company has experienced a significant drop in demand for feed additives due to oversupply in the pig farming industry and weak consumption, leading to a decrease in procurement needs[5]. - Despite the challenges in feed additives, the company has increased sales and promotion efforts for feed products, which have shown some growth[6]. Cost and Profitability - The overall decline in gross profit margin is attributed to rising production costs and reduced selling prices of single-strain products within the microbial preparations category[6].
大禹生物(871970) - 2023 Q4 - 年度业绩预告